Clinical Trial

Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion

Study acronym: CSWT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomised controlled trial aimed to demonstrate the effect of cardiac extracorporeal shock wave therapy (CSWT) on the angiogenesis effect of myocardium by determining myocardial perfusion and left ventricular function in patients with coronary artery disease (CAD) when measured by cardiac MRI before and after the treatment.
Trial Details
NCT Number NCT07068399
Lead Sponsor The University of Hong Kong
Conditions Coronary Artery Disease
Enrollment 100 participants
Start Date 2020-09-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-16